All stories tagged :

Pr Newswire

4DMT to Participate in Chardan’s 9th Annual Genetic Medicines Conference

Tháng 10 14

ONWARD® Medical Announces Results of Annual General Meeting of Shareholders

1 năm ago

Tonix Pharmaceuticals Announces Closing of $4.0 Million Public Offering

1 năm ago

Gain Therapeutics Announces Proposed Public Offering

1 năm ago

Modern Meadow and Earthletica Announce World’s First Sustainable Collaboration on Bronte...

1 năm ago

CELEBRITY XCEL KEEL LAYING CEREMONY MARKS NEW LEVEL OF EXCELLENCE FOR...

1 năm ago

TraceLink MINT Awarded 2024 Supply Chain Visibility Solution of the Year...

1 năm ago

ZKH Group Limited Announces US$50 Million Share Repurchase Program

1 năm ago

NaaS Technology Inc. Announces Completion of ADS Ratio Change

1 năm ago

Opus Genetics Announces $1.7 Million in Project-based Funding from the Foundation...

1 năm ago

Umoja Biopharma Announces Publication in Blood Highlighting Successful Generation of In...

1 năm ago

1 2 3 … 752 753 754 755 756 757 758 … 761 762 763 Page 755 of 763

Featured

Opus Genetics to Participate in Chardan’s 9th Annual Genetic Medicines Conference

10 giờ ago

Hawx Services Celebrates Serving 14 States Across Nationwide

10 giờ ago

AICB Launches FSF Xcel: Malaysia’s First Industry-Wide Skills Assessment Platform to...

10 giờ ago

Morgan Stanley Raises JOYY (JOYY.US) Target Price from US$40 to US$62...

10 giờ ago

10 giờ ago

Opus Genetics to Participate in Chardan’s 9th Annual Genetic Medicines Conference

RESEARCH TRIANGLE PARK, N.C., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (Nasdaq: IRD) (the “Company” or “Opus Genetics”), a clinical-stage biopharmaceutical company developing gene therapies for the treatment of inherited retinal diseases (IRDs) and small molecule therapies for other ophthalmic disorders, announced today that Ash...